Philip is a venture partner at Third Rock Ventures and has served as chief medical officer of Goldfinch Bio, co-founder of Fulcrum Therapeutics, co-founder and chief medical officer of Voyager Therapeutics, chief medical officer of Bluebird Bio, co-founder of Edimer, among other startup roles. He served as chairman and CEO of Interleukin Genetics. He earned his medical degree at the Yale School of Medicine.
Philip has authored or co-authored more than 100 articles in scholarly journals and has published seven books including most recently Orphan: The Quest to Save Children with Rare Genetic Disorders. Phil currently serves on the Advisory Board to the Boston University School of Public Health, and has served as a trustee emeritus of Cornell University, an Overseer of Weill Cornell Medical College.